Global Soy Isoflavones Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Raw-Material Type;

Genetically Modified (Gm) and Non-Genetically Modified (Non-Gm) Soy.

By Product Type;

Genistein, Daidzein and Glucitein.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn139019709 Published Date: March, 2025 Updated Date: May, 2025

Introduction

Global Soy Isoflavones Market (USD Million), 2021 - 2031

In the year 2024, the Global Soy Isoflavones Market was valued at USD 1,820.81 million. The size of this market is expected to increase to USD 3,616.54 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 10.3%.

The Global Soy Isoflavones Market is driven by increasing consumer awareness of the health benefits associated with these naturally occurring compounds found in soybeans. Isoflavones, such as genistein and daidzein, are phytoestrogens known for their potential to mimic estrogenic activity in the body, offering various health benefits. They are widely used in dietary supplements, functional foods, and pharmaceuticals, particularly for their role in promoting cardiovascular health, supporting bone health, and alleviating menopausal symptoms.

Key drivers of the Global Soy Isoflavones Market include the rising prevalence of chronic diseases and conditions where soy isoflavones are believed to provide therapeutic benefits. As lifestyles become more sedentary and dietary habits shift towards healthier options, the demand for functional ingredients like soy isoflavones continues to grow. Moreover, advancements in extraction technologies and formulation techniques are enhancing the bioavailability and efficacy of soy isoflavones in various consumer products, driving market expansion.

However, the market faces challenges such as fluctuating raw material costs, regulatory complexities, and varying consumer perceptions of soy-based products. Competition from alternative sources of phytoestrogens and concerns regarding the safety and efficacy of soy isoflavones in certain populations also pose constraints to market growth. Nonetheless, opportunities exist for market players to innovate by developing novel applications, conducting clinical research to validate health claims, and expanding into emerging markets where health and wellness trends are gaining momentum. As the scientific understanding of soy isoflavones evolves, their role in preventive healthcare and nutritional supplementation is expected to strengthen, further bolstering market prospects globally.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Raw-Material Type
    2. Market Snapshot, By Product Type
    3. Market Snapshot, By Region
  4. Global Soy Isoflavones Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Health benefits awareness
        2. Demand for functional foods
        3. Technological advancements
      2. Restraints
        1. Raw material cost fluctuations
        2. Regulatory hurdles
        3. Consumer perception challenges
      3. Opportunities
        1. Product innovation
        2. Emerging market expansion
        3. Clinical validation
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Soy Isoflavones Market, By Raw-Material Type, 2021 - 2031 (USD Million)
      1. Genetically Modified (Gm)
      2. Non-Genetically Modified (Non-Gm) Soy
    2. Global Soy Isoflavones Market, By Product Type, 2021 - 2031 (USD Million)
      1. Genistein
      2. Daidzein
      3. Glucitein
    3. Global Soy Isoflavones Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Frutarom Health (SoyLife)
      2. Archer Daniels Midland Company (ADM)
      3. Koninklijke DSM N.V. (DSM)
      4. SunOpta Inc.
      5. BASF SE
      6. Cargill Inc
      7. Novogen Limited
      8. E. I. du Pont de Nemours and Company
  7. Analyst Views
  8. Future Outlook of the Market